Strategic Initiative

Slingshot members are tracking this corporate initiative:

Allergan Acquires Topical Dermatology Company Topokine Therapeutics Adding Non-Invasive Fat Reduction Development Program

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
AGN Community voting in process
Topokine Therapeutics Community voting in process

Additional Information

Additional Relevant Details -- Adds global rights to XAF5, potential first-in-class topical treatment for steatoblepharon, or undereye bags -
-- XAF5 currently being studied in phase 2b/3 pivotal trial --
-- Adds to Allergan's robust mid-to-late stage pipeline, reinforces leadership in aesthetics innovation --
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date:
Apr 21, 2016
Projected Implementation:
Q2, 2016
Relevance Tracked Until:
Q3, 2016
Related Projects Image
  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Non-invasive Fat Reduction, Xaf5, Steatoblepharon